AVITA Medical Director Woody Fralin Receives Equity Awards in January 2026

This Form 4 filing reports that Woody Joseph Fralin, a non-executive director of AVITA Medical, Inc., received equity awards in January 2026 that were subject to stockholder approval. On January 5, 2026, Fralin received 40,547 restricted stock units (RSUs) vesting in three equal annual installments and 29,446 stock options with an exercise price of $3.47. On January 20, 2026, he received an additional 22,214 RSUs vesting after 12 months and 16,133 stock options with an exercise price of $3.77. The company's stockholders approved all these awards on June 3, 2026. Following these transactions, Fralin holds 82,761 shares of common stock (including unvested RSUs), 29,446 stock options expiring in 2036, and 16,133 stock options expiring in 2036. The filing demonstrates the company's compensation practices for non-executive directors and the requirement for stockholder approval of certain equity awards.